Search results
Ex-Fauci adviser shared ‘confidential’ NIH info with EcoHealth about COVID biosafety levels: docs
New York Post· 7 days agoThe SARS-CoV-2 research had been conducted at a Biosafety Level 2 (BSL-2) lab, though another...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 4 days agoOne study published in PLOS Pathogens in 2022 found that long COVID patients had 100 times the...
The Covid Revisionists Are Endangering Us All
The Nation· 23 hours agoAt the same time, we’re being told we got it all wrong in our response to Covid. This “nevertheless” carries a lot of weight for Wallace-Wells, because...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 23 hours agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...
Long COVID Taste Loss May Not Involve Taste Buds
MedPage Today· 3 days agoStudy attempts to untangle taste and olfactory dysfunction 1 year after infection
How Ugandan Tobacco Farmers Inadvertently Spread Bat-Borne Viruses
Scientific American· 3 days agoA new paper published this week in Communications Biology shines rare light on one such case study:...
Dozens of COVID virus mutations arose in man with longest known case, research finds
Medical Xpress· 7 days agoWorse, several of the mutations were in the COVID spike protein, indicating that the virus had...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
How Vir found the one: CEO Marianne De Backer
FierceBiotech· 7 days agoVir Biotechnology conducted a worldwide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne De Backer, Ph.D., because of her...
Vaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving Average of $0.88
ETF DAILY NEWS· 9 hours agoVaxart, Inc. (NASDAQ:VXRT – Get Free Report) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.88 and traded ...
